manicmums.com

New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

4.6 (191) · $ 15.00 · In stock

SARS-CoV-2 Spike Protein Targeted for Vaccine

How Furin and ACE2 Interact with the Spike on SARS-CoV-2 - Assay Genie

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

News & Comment Cellular & Molecular Immunology

Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein - ScienceDirect

Vaccines ++ – COVID Reference

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics, Virology Journal

Vaccines ++ – COVID Reference

Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach - AJMB: Volume 14, Issue 1, Year 2022 - AJMB